Name: PGAP2 | Sequence: fasta or formatted (315aa) | NCBI GI: 7657102 | |
Description: FGF receptor activating protein 1 isoform 1
|
Referenced in:
| ||
Other entries for this name:
alt prot [307aa] FGF receptor activating protein 1 isoform 2 alt prot [161aa] FGF receptor activating protein 1 isoform 3 | |||
Composition:
Amino acid Percentage Count Longest homopolymer A alanine 7.0 22 2 C cysteine 4.4 14 2 D aspartate 2.5 8 1 E glutamate 3.8 12 2 F phenylalanine 9.8 31 3 G glycine 3.8 12 2 H histidine 3.2 10 1 I isoleucine 5.1 16 2 K lysine 2.2 7 2 L leucine 11.4 36 2 M methionine 2.5 8 1 N asparagine 3.2 10 1 P proline 4.4 14 1 Q glutamine 1.9 6 1 R arginine 5.1 16 1 S serine 7.0 22 3 T threonine 7.3 23 2 V valine 7.9 25 2 W tryptophan 3.2 10 2 Y tyrosine 4.1 13 1 |
Comparative genomics:
Search single species RefSeq proteins at NCBI
Search summary
Figure data | ||
Related human proteins:Protein Relative score Description Self-match 1.000 FGF receptor activating protein 1 isoform 1 PGAP2 0.686 FGF receptor activating protein 1 isoform 2 USP24 0.011 ubiquitin specific protease 24 OR8K3 0.008 olfactory receptor, family 8, subfamily K, member 3 ... CATSPERG 0.008 hypothetical protein LOC57828 CELA2B 0.008 elastase 2B preproprotein CTRC 0.006 chymotrypsin C preproprotein LOC100131755 0.006 PREDICTED: similar to hCG1792883 LOC100131755 0.006 PREDICTED: similar to hCG1792883 LOC100131755 0.006 PREDICTED: similar to hCG1792883 CELA2A 0.006 elastase 2A preproprotein TSPAN31 0.006 sarcoma amplified sequenceHuman BLASTP results (used to prepare the table) |
Gene descriptions are from NCBI RefSeq. Search results were obtained with NCBI BLAST and RefSeq entries. When identical proteins are present, the self-match may not be listed first in BLASTP output. In such cases, the table above has been reordered to place it first.
See About the Figures for the scoring system used in the figure above right. The same scoring system was used in the table of BLASTP results.
Guide to the Human Genome
Copyright © 2010 by Stewart Scherer. All rights reserved.